Title Phenotype Institution Algorithm Typesort descending Total Cases Total Controls PPV Sensitivity
AAA Implementation - Columbia Abdominal Aortic Aneurysm ( AAA ) Columbia University Case, Control 10 1,354
Marshfield implementation caMRSA Marshfield Clinic Research Foundation Case, Control 1.00, 1.00 1.00, 1.00
Group Health/University of Washington CAAD Implementation CAAD (Carotid Artery Atherosclerosis Disease) Group Health/University of Washington Case, Control 300 4,475 0.96, 1.00
Harvard Implementation Appendicitis Case, Control 877 771
CRS merged all sites CRS (Chronic Rhinosinusitis) Case, Control
Columbia - Hearing Loss Hearing Loss Columbia University Medical Center Case, Control 97 2,334
Columbia Implementation Pneumonia- VUMC eMERGE v5.1 Columbia University Case, Control 156 8,015 0.96
CHOP Depression Depression Case, Control
CHOP Type 1 Diabetes CHOP Case, Control
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 1.00, 1.00 1.00, 1.00
Marshfield Venous Thromboembolism implementation Venous Thromboembolism (VTE) Marshfield Clinic Research Foundation Case, Control 50 49 0.98, 1.00
Geisinger caMRSA Implementation caMRSA Geisinger Case, Control 25 25 0.96, 1.00 0.96
Marshfield Implementation 2 CAAD (Carotid Artery Atherosclerosis Disease) Marshfield Clinic Research Foundation Case, Control 193 4,170 1.00, 1.00
GH/UW Implementation Appendicitis Case, Control 0 1,761
Geisinger Implementation Hearing Loss Geisinger Case, Control 336 6,479
Marshfield Implementation Pneumonia- VUMC eMERGE v5.1 Marshfield Clinic Research Institute Case, Control
NU depression data Depression Northwestern University Case, Control
MGB Type 1 Diabetes Case, Control
VU E3 implementation Clostridium Difficile Colitis Vanderbilt University Medical Center Case, Control
Venous Thromboembolism Implementation - Columbia Venous Thromboembolism (VTE) Columbia University Case, Control 419 2,574
Vanderbilt Implementation of caMRSA caMRSA Vanderbilt University Case, Control 262 2,313
Mayo Clinic CAAD Evaluation CAAD (Carotid Artery Atherosclerosis Disease) Mayo Clinic Case, Control 1.00 0.72
CHOP eMERGE III Migraine CHOP Case, Control
Mayo clinic hearing loss implementation Hearing Loss Mayo Clinic Case, Control
NU eMERGE pneumonia data Pneumonia- VUMC eMERGE v5.1 Northwestern University Case, Control

Pages